Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ISHLT 2026
Start date: Apr 21, 2026 End date: Apr 25, 2026
The International Society for Heart & Lung Transplantation’s (ISHLT) 46th Annual Meeting & Scientific Sessions (ISHLT2026) will take place from 21–25 April 2026 at the Metro Toronto Convention Centre in Toronto, Ontario, Canada. This multidisciplinary, international meeting is one of the largest gatherings dedicated to advanced heart and lung failure, transplantation, mechanical circulatory… View more

Heart Failure
HFSA 25: The ATTRibute-CM Trial
Author(s): Ahmad Masri Added: 8 months ago
HFSA 2025 - Post hoc analysis of ATTRibute-CM reveals significant reduction in cardiovascular mortality and death after 30 months of acoramidis in patients with ATTR-CM.Dr Ahmad Masri (Oregon Health & Science University, US) joins us to discuss a post hoc exploratory analysis from the ATTRibute-CM trial examining the timing and magnitude of cardiovascular outcome reductions with acoramidis in… View more

Heart Failure
Job title: Associate Physician
Dr Michelle O’Donoghue, is an Associate Physician in the Cardiology Division of Brigham and Women’s Hospital, an Affiliate Physician in the Cardiology Division of Massachusetts General Hospital and an Assistant Professor in Medicine at Harvard Medical School in Boston, Massachusetts, US. She is an investigator in the Thrombolysis in Myocardial Infarction (TIMI) Study Group, founded by Dr Eugene… View more
Job title: Professor Emeritus of Cardiology
Heart Rate Lowering Benefits are Context-Dependent, Meta-Analysis Finds
Added: 11 months ago Source:  Radcliffe Cardiology
AUTHOR: Jennifer ThomasThe long-standing debate over the benefits of heart rate (HR)-lowering drug treatment, particularly in patients with hypertension, has been addressed in a new large-scale meta-analysis. The findings, published in the European Heart Journal, suggest that the advantages of reducing HR are highly dependent on the patient's underlying clinical condition, with significant… View more

MI/ACS

Prevention & Chronic Conditions
Cardiogenic Shock in Restrictive Cardiomyopathies
Author(s): Ossama K Abou Hassan , Ebere Chukwu , John Schmittner , et al Added: 11 months ago

Heart Failure
Sing-Chien Yap
Job title: Cardiologist
Dr. Sing-Chien Yap is an academic cardiologist-electrophysiologist in the Erasmus Medical Center in Rotterdam (NL). His main areas of focus are catheter ablation, cardiac device therapy and lead extraction. His research included arrhythmia management in adults with congenital heart disease with special emphasis on devices and catheter ablation. View more
Job title: Interventional Cardiologist
DrMichael Haude is anInterventional Cardiologist atRheinlandklinkum, Neuss, DE. He is President of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and Board Member of the European Society of Cardiology (ESC). Dr Haude's interests include drug eluting stents, bioresorbable scaffolds, complex PCI, structural heart disease intervention and complication management… View more
Job title: Cardiologist
Dr Matthew Ryan is a consultant cardiologist at St Thomas’ Hospital and a senior lecturer at King’s College London, with subspecialist expertise in interventional cardiology. His clinical practice covers both general and interventional cardiology, managing a wide range of heart-related symptoms such as chest pain, palpitations, dizziness, fainting, breathlessness, and leg swelling. He has… View more
Research Area(s) / Expertise: Job title: Associate Professor of Medicine
Dr Orly Vardeny is Associate Professor of Medicine at the University of Minnesota in Minneapolis. Her research interests include maximising the benefit of pharmacologic therapy in patients with heart failure and optimising vaccination strategies in patients with cardiac disorders. She has led several multi-center, randomized clinical trials evaluating influenza vaccines in patients with high-risk… View more